Latest Breaking News On - Neximmune inc - Page 19 : comparemela.com

Brianne Nadeau ends effort to reinstate proof of Covid vaccination requirement for businesses

Brianne Nadeau ends effort to reinstate proof of Covid vaccination requirement for businesses
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

United statesMontgomery countyLaquandra nesbittMuriel bowserBrianne nadeauEli lillyKristi jonesScott carmerDc healthA montgomery county circuit courtDc councilWashington postNeximmune incAssistant managing editorWashington business journalMayor muriel bowser

Year in review: D C region sees a SPAC and IPO frenzy - Washington Business Journal

Year in review: D C region sees a SPAC and IPO frenzy - Washington Business Journal
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

United statesCollege parkJohn delaneyDonald trumpGary genslerReggie aggarwalSteve caseMark einDigital world acquisition corpFluence energy incSpartacus acquisition corpFiscalnote incPrivia health group incIonq incCollege park ionSensei biotherapeutics inc

NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma

NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesJuanc varelaRobertd knightScott carmerDaniel bednarikMaung myo htutLauren suarezMathias oelkeVineetha edavanaEmily luSojung kimAmerican society of hematologyExchange commissionNeximmune incCorporate affairsInitial phase

NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results

Initial Phase 1/2 data presented at the 63rd American Society of Hematology (ASH) Annual Meeting and ExpositionPhase 1/2 study of NEXI-002 as a monotherapy.

United statesJuanc varelaRobertd knightScott carmerDaniel bednarikMaung myo htutLauren suarezMathias oelkeVineetha edavanaEmily luSojung kimAmerican society of hematologyExchange commissionNeximmune incCorporate affairsInitial phase

The Week Ahead in Biotech (Dec 6–Dec 11)

The Omicron variant concerns were front and center in the markets in the week ended Dec. 3, and .

United statesUnited kingdomSan antonioMerck keytrudaSacituzumab govitecanCytokinetics incorporatedCardiovascular and renal drugs advisory committeeZymeworks incBioscience incInternational symposium on amyotrophic lateral sclerosisJaguar health incMereo biopharma groupAprea therapeutics incContext therapeutics incOncosec medical incorporatedPfizer inc